No Data
No Data
Express News | Enveric Biosciences Announces Preclinical Results Confirming Potential of Eb-003 to Be Dosed Orally
Enveric Stock Climbs 7% on Deal for Radiation Dermatitis Drug
Aries Science Inks Licensing Deal For Enveric Biosciences' Radiation Dermatitis Topical Product
Express News | Enveric Biosciences-Co to Be Eligible to Receive Milestone Payments of up to $61 Mln on Future Sales, IF All Conditions Met
Express News | Enveric Biosciences Inc- Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement
New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
No Data